Advertisement
Home Blog Page 2139
Patients who previously had a false-positive breast or prostate cancer screening test result are more likely to have future screenings

Cancer Screening More Likely After a Previous False Positive

Findings for both men and women with a false-positive prostate or breast cancer test result
For patients undergoing head and neck cancer surgery

Celecoxib Lowers Opioid Use Post Head & Neck Cancer Surgery

Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction
For individuals with major depression and bipolar disorder

Grip Strength Indicative of Cognition in Major Depression

Positive association with performance on cognitive tasks for those with depression, bipolar disorder
In patients with atopic dermatitis and birch pollen allergy

Birch Pollen-Related Foods Can Trigger Dermatitis Reactions

Intake may lead to aggravation of symptoms in patients with atopic dermatitis, birch pollen allergy
A smartphone app is associated with improved short-term adherence to a cutaneous foam treatment for psoriasis

Phone App Linked to Improved Psoriasis Treatment Adherence

App intervention group also had greater reduction in psoriasis severity than non-intervention group
The choroidal thickness changes in patients with untreated diabetes mellitus over time

Choroidal Thickness Changes in Patients With Untreated DM

But in group treated for diabetes, no significant differences in choroidal layer thicknesses
Targeted diabetes screening based only on age and weight criteria will identify approximately half of U.S. adults with dysglycemia

Age- and Weight-Based Screening Identifies Half With Prediabetes

Expanded screening criteria based on risk factors improve detection for minorities
Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia.

FDA Approves First Drug for Rare Form of Rickets

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia
Elevated fibroblast growth factor 23 is associated with increased risk of recurrent major cardiovascular events in patients after an acute coronary syndrome

High FGF-23 Linked to Recurrent Cardiac Events After ACS

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization
Medical cannabis and/or its synthetic extracts should not be used for treating patients with obstructive sleep apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea